Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

Phase 1/2 Clinical Trial of CP-506 (HAP) in Monotherapy or With Carboplatin or ICI

Maastricht University Medical Center · 2023
ClinicalTrials.gov · Datasets · License: Public Domain · 2023
Open Source ↗
head-and-neck-cancerimmune-checkpoint-inhibitorovarian-cancerpancreatic-cancerprostate-cancertriple-negative-breast-cancer
unspecified adult solid tumor, protocol specific, homologous recombination dna repair defects, fanconi anaemia dna repair defects, triple negative breast cancer, ovarian cancer, prostate cancer, pancreatic cancer, head and neck cancer, hypoxia activated prodrug, alkylating agents, carboplatin, immune checkpoint inhibitor
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗
Record · ID 846956
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.